Dopamine D1 and D2 receptors are distinctly associated with rest-activity rhythms and drug reward

J Clin Invest. 2021 Sep 15;131(18):e149722. doi: 10.1172/JCI149722.

Abstract

BACKGROUNDCertain components of rest-activity rhythms such as greater eveningness (delayed phase), physical inactivity (blunted amplitude), and shift work (irregularity) are associated with increased risk for drug use. Dopaminergic (DA) signaling has been hypothesized to mediate the associations, though clinical evidence is lacking.METHODSWe examined associations between rhythm components and striatal D1 (D1R) and D2/3 receptor (D2/3R) availability in 32 healthy adults (12 female, 20 male; age 42.40 ± 12.22 years) and its relationship to drug reward. Rest-activity rhythms were assessed by 1-week actigraphy combined with self-reports. [11C]NNC112 and [11C]raclopride positron emission tomography (PET) scans were conducted to measure D1R and D2/3R availability, respectively. Additionally, self-reported drug-rewarding effects of 60 mg oral methylphenidate were assessed.RESULTSWe found that delayed rhythm was associated with higher D1R availability in caudate, which was not attributable to sleep loss or so-called social jet lag, whereas physical inactivity was associated with higher D2/3R availability in nucleus accumbens (NAc). Delayed rest-activity rhythm, higher caudate D1R, and NAc D2/3R availability were associated with greater sensitivity to the rewarding effects of methylphenidate.CONCLUSIONThese findings reveal specific components of rest-activity rhythms associated with striatal D1R, D2/3R availability, and drug-rewarding effects. Personalized interventions that target rest-activity rhythms may help prevent and treat substance use disorders.TRIAL REGISTRATIONClinicalTrials.gov: NCT03190954.FUNDINGNational Institute on Alcohol Abuse and Alcoholism (ZIAAA000550).

Keywords: Addiction; Molecular biology; Neuroscience.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Actigraphy
  • Adult
  • Central Nervous System Stimulants / administration & dosage
  • Circadian Rhythm / physiology*
  • Corpus Striatum / physiology
  • Female
  • Humans
  • Male
  • Methylphenidate / administration & dosage
  • Middle Aged
  • Motor Activity / physiology
  • Positron-Emission Tomography
  • Receptors, Dopamine D1 / physiology*
  • Receptors, Dopamine D2 / physiology*
  • Rest / physiology
  • Reward*
  • Substance-Related Disorders / etiology*
  • Substance-Related Disorders / physiopathology*
  • Young Adult

Substances

  • Central Nervous System Stimulants
  • DRD2 protein, human
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Methylphenidate

Associated data

  • ClinicalTrials.gov/NCT03190954